Tags

Type your tag names separated by a space and hit enter

Dengue: a continuing global threat.
Nat Rev Microbiol. 2010 Dec; 8(12 Suppl):S7-16.NR

Abstract

Dengue fever and dengue haemorrhagic fever are important arthropod-borne viral diseases. Each year, there are ∼50 million dengue infections and ∼500,000 individuals are hospitalized with dengue haemorrhagic fever, mainly in Southeast Asia, the Pacific and the Americas. Illness is produced by any of the four dengue virus serotypes. A global strategy aimed at increasing the capacity for surveillance and outbreak response, changing behaviours and reducing the disease burden using integrated vector management in conjunction with early and accurate diagnosis has been advocated. Antiviral drugs and vaccines that are currently under development could also make an important contribution to dengue control in the future.

Authors+Show Affiliations

Instituto de Medicina Tropical, 'Pedro Kouri', PO Box 601, Marianao 13, Ciucad de la Habana, Cuba.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

21079655

Citation

Guzman, Maria G., et al. "Dengue: a Continuing Global Threat." Nature Reviews. Microbiology, vol. 8, no. 12 Suppl, 2010, pp. S7-16.
Guzman MG, Halstead SB, Artsob H, et al. Dengue: a continuing global threat. Nat Rev Microbiol. 2010;8(12 Suppl):S7-16.
Guzman, M. G., Halstead, S. B., Artsob, H., Buchy, P., Farrar, J., Gubler, D. J., Hunsperger, E., Kroeger, A., Margolis, H. S., Martínez, E., Nathan, M. B., Pelegrino, J. L., Simmons, C., Yoksan, S., & Peeling, R. W. (2010). Dengue: a continuing global threat. Nature Reviews. Microbiology, 8(12 Suppl), S7-16. https://doi.org/10.1038/nrmicro2460
Guzman MG, et al. Dengue: a Continuing Global Threat. Nat Rev Microbiol. 2010;8(12 Suppl):S7-16. PubMed PMID: 21079655.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Dengue: a continuing global threat. AU - Guzman,Maria G, AU - Halstead,Scott B, AU - Artsob,Harvey, AU - Buchy,Philippe, AU - Farrar,Jeremy, AU - Gubler,Duane J, AU - Hunsperger,Elizabeth, AU - Kroeger,Axel, AU - Margolis,Harold S, AU - Martínez,Eric, AU - Nathan,Michael B, AU - Pelegrino,Jose Luis, AU - Simmons,Cameron, AU - Yoksan,Sutee, AU - Peeling,Rosanna W, PY - 2010/11/17/entrez PY - 2010/11/17/pubmed PY - 2011/5/19/medline SP - S7 EP - 16 JF - Nature reviews. Microbiology JO - Nat. Rev. Microbiol. VL - 8 IS - 12 Suppl N2 - Dengue fever and dengue haemorrhagic fever are important arthropod-borne viral diseases. Each year, there are ∼50 million dengue infections and ∼500,000 individuals are hospitalized with dengue haemorrhagic fever, mainly in Southeast Asia, the Pacific and the Americas. Illness is produced by any of the four dengue virus serotypes. A global strategy aimed at increasing the capacity for surveillance and outbreak response, changing behaviours and reducing the disease burden using integrated vector management in conjunction with early and accurate diagnosis has been advocated. Antiviral drugs and vaccines that are currently under development could also make an important contribution to dengue control in the future. SN - 1740-1534 UR - https://www.unboundmedicine.com/medline/citation/21079655/full_citation L2 - http://dx.doi.org/10.1038/nrmicro2460 DB - PRIME DP - Unbound Medicine ER -